Diastolic Dysfunction, an Underestimated New Challenge in Dialysis.

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Heart failure (HF) is highly prevalent in the general population and significantly more common in chronic kidney disease (CKD) patients.
• Heart failure with preserved ejection fraction (HFpEF) affects over half of dialysis patients, yet remains under-recognized and under-researched in CKD.
• Limited data exist on the clinical profiles and outcomes of HFpEF specifically within the CKD population.

Purpose of the Study:

• To critically appraise the current understanding of HFpEF diagnosis in CKD.
• To evaluate the clinical impact and management strategies for HFpEF in CKD patients.
• To focus on novel diagnostic criteria for HFpEF and their implications for dialysis patients.

Main Methods:

• Literature review and critical appraisal of existing studies.
• Analysis of diagnostic criteria for HFpEF.
• Examination of clinical data and outcomes in CKD and dialysis populations.

Main Results:

• HFpEF is a significant clinical challenge in CKD, particularly in dialysis patients.
• Existing diagnostic criteria for HFpEF may require adaptation for the CKD population.
• Further research is needed to elucidate the specific clinical profiles and optimize management of HFpEF in CKD.

Conclusions:

• HFpEF represents a substantial burden in CKD patients, necessitating improved recognition and research.
• New diagnostic approaches are crucial for accurate HFpEF identification in CKD.
• Understanding and addressing HFpEF is vital for improving outcomes in dialysis patients.